Online inquiry

IVTScrip™ mRNA-Human ARHGEF11, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25008MR)

This product GTTS-WK25008MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF11 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001377418.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9826
UniProt ID O15085
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF11, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25008MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16138MR IVTScrip™ mRNA-Human ANKS3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKS3
GTTS-WK13730MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK12553MR IVTScrip™ mRNA-Human ADIPOR1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADIPOR1
GTTS-WK12546MR IVTScrip™ mRNA-Human ADGRL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRL2
GTTS-WK16354MR IVTScrip™ mRNA-Human AMN1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AMN1
GTTS-WK25324MR IVTScrip™ mRNA-Human ARID3B, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARID3B
GTTS-WK7505MR IVTScrip™ mRNA-Human 3C4, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA 3C4
GTTS-WK27958MR IVTScrip™ mRNA-Human ARAP3, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARAP3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW